This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Brugada-Bellsolà F, Teixidor Rodríguez P, Rodríguez-Hernández A, Garcia-Armengol R, Tardáguila M, González-Crespo A, Domínguez CJ, Rimbau JM (2019) Growth prediction in asymptomatic meningiomas: the utility of the AIMSS score. Acta Neurochir 161:2233–2240. https://doi.org/10.1007/s00701-019-04056-3
Hashiba T, Hashimoto N, Izumoto S, Suzuki T, Kagawa N, Maruno M, Kato A, Yoshimine T (2009) Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg 110:675–684
Huang RY, Dunn I, Bi WL, Weller M, Kaley T, Blakeley J, Galanis E, Preusser M, McDermott M, Rogers L, Raizer J, Schiff D, Soffietti R, Tonn J-C, Vogelbaum M, Weber D, Reardon DA, Wen PY (2018) Proposed response assessment and endpoints for meningioma clinical trials: report from the response assessment in neuro-oncology working group. Neuro-Oncology 21:26–36. https://doi.org/10.1093/neuonc/noy137
Islim AI, Kolamunnage-Dona R, Mohan M, Moon RDC, Crofton A, Haylock BJ, Rathi N, Brodbelt AR, Mills SJ, Jenkinson MD (2019) A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas. Neuro-Oncology. https://doi.org/10.1093/neuonc/noz160
Islim AI, Mohan M, Moon RDC, Srikandarajah N, Mills SJ, Brodbelt AR, Jenkinson MD (2019) Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes. J Neuro-Oncol 142:211–221. https://doi.org/10.1007/s11060-019-03104-3
Kattan MW, Hess KR, Amin MB, Lu Y, Moons KGM, Gershenwald JE, Gimotty PA, Guinney JH, Halabi S, Lazar AJ, Mahar AL, Patel T, Sargent DJ, Weiser MR, Compton C, members of the APMC (2016) American joint committee on cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin 66:370–374. https://doi.org/10.3322/caac.21339
Lee EJ, Kim JH, Park ES, Kim Y-H, Lee JK, Hong SH, Cho YH, Kim CJ (2017) A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas. J Neurosurg:1–10
Lee EJ, Park JH, Park ES, Kim JH (2017) “Wait-and-see” strategies for newly diagnosed intracranial meningiomas based on the risk of future observation failure. World Neurosurg 22:22
Nakasu S, Nakasu Y, Fukami T, Jito J, Nozaki K (2011) Growth curve analysis of asymptomatic and symptomatic meningiomas. J Neuro-Oncol 102:303–310
Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-Oncology 21:v1–v100. https://doi.org/10.1093/neuonc/noz150
Steyerberg EW, Uno H, Ioannidis JPA, van Calster B, Ukaegbu C, Dhingra T, Syngal S, Kastrinos F (2018) Poor performance of clinical prediction models: the harm of commonly applied methods. J Clin Epidemiol 98:133–143. https://doi.org/10.1016/j.jclinepi.2017.11.013
Conflict of interest
The authors declare that they have no conflict of interest.
For this study type, ethical or institutional review board approval is not required.
For this study type, informed consent is not required.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Tumor - Meningioma
About this article
Cite this article
Islim, A.I., Millward, C.P., Martin-McGill, K.J. et al. Clinical studies of incidental intracranial meningiomas—towards high-quality evidence-based practice. Acta Neurochir (2020). https://doi.org/10.1007/s00701-020-04214-y